#mHealth Market Demands

[market-spy]

Patient Engagement Solutions Market Forecast to Grow at 17.54%  CAGR from 2024 to 2031 | SkyQuest Technology

The Global Patient Engagement Solutions Market was valued at USD 16.58 billion in 2022 and is projected to grow to USD 70 billion by 2031, with a compound annual growth rate (CAGR) of 17.54% during the forecast period (2024-2031).

Market Overview

Patient engagement solutions refer to tools like online patient portals that enable medical organizations to interact effectively with their patients. The growing awareness of mobile health technologies, an aging population, and government incentives are driving demand for these solutions. Patients increasingly use technology to monitor and manage their health, particularly in cases of chronic illnesses. Innovations in health tracking, wearable devices, and remote monitoring are further boosting this market.

Get your free sample: https://www.skyquestt.com/sample-request/patient-engagement-solutions-market

Key Market Dynamics

Drivers: The advancement of mobile apps and wearables, increased awareness of chronic disease management, and government initiatives such as the Meaningful Use Act are propelling market growth.

Restraints: Strict regulatory frameworks like HIPAA and concerns over the protection of patient data are hindering wider adoption of patient engagement solutions.

Segmental Analysis Segmental Analysis

Component

Software (Standalone Software, and Services

Therapeutic Area

Chronic Diseases, Fitness, and Others

Functionality

Telehealth, E-Prescribing, and Billing & Payments

End Users

Providers and Payers Regional Insights

North America leads the market, driven by the widespread adoption of mobile health (mHealth) and electronic health records (EHRs). Government support and significant investments also contribute to regional dominance.

Asia Pacific is the fastest-growing region, with rising demand for modern healthcare systems, an increase in smartphone users, and government initiatives supporting patient engagement solutions.

Ask for customization: https://www.skyquestt.com/speak-with-analyst/patient-engagement-solutions-market

Competitive Landscape

IBM (US) 

McKesson Corporation (US) 

Allscripts (US) 

ResMed (US) 

Epic Systems Corporation (US) 

Orion Health (New Zealand) 

GetWellNetwork (US) 

Athenahealth (US) 

Oneview Healthcare (Ireland) 

MEDITECH (US) 

Cognizant (US) 

Symphony Care (US) 

Harris Healthcare (US) 

Recent Developments

Engage Technologies Group Inc. partnered with APX Platform in April 2023 to create an industry-disrupting Practice Performance System aimed at improving patient engagement.

Athenahealth Inc. implemented its cloud-based EHR and patient engagement solution with LCH Health and Community Services in May 2023.

Go through the detailed TOC of the report: https://www.skyquestt.com/report/patient-engagement-solutions-market

Market Trends

The rise in personalized care and the adoption of mobile technology are major trends shaping the patient engagement solutions market. Mobile health apps and wearables are enabling patients to monitor and manage their health on their own, fostering higher patient engagement.

Conclusion

The patient engagement solutions market is experiencing significant growth driven by technological advancements and increasing patient awareness. Major players are competing in a rapidly evolving field, introducing innovative solutions and forming strategic partnerships to capture market share. The market is expected to expand substantially through 2031, with increasing demand for personalized healthcare solutions and remote monitoring technologies.

About Us:

SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.

We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.

Contact:

Mr. Jagraj Singh

Skyquest Technology

1 Apache Way,

Westford,

Massachusetts 01886

USA (+1) 351-333-4748

Email: sales@skyquestt.com

Visit Our Website: https://www.skyquestt.com/

[industrynewsupdates]

Clinical Trials Procurement Intelligence 2024-2030: What You Need to Know

This clinical trials market is anticipated to grow at a CAGR of 6.49% from 2024 to 2030. North America is the leading region in this category, accounting for over 50.3% of the market share in 2023. This is expected to continue in the forecast period as well, due to several factors, including increased R&D investments and the adoption of new technologies. For example, the use of virtual services in clinical trials is becoming increasingly popular, and this is expected to drive growth in the North American market.

This category is driven by many key factors, including the surge in demand for outsourcing clinical trials, the increasing prevalence of chronic diseases, and the increased investments in R&D by pharmaceutical and biotechnological companies. The outsourcing of this category is becoming increasingly popular, as it allows pharmaceutical companies to focus on their core competencies and to save time and money. The increasing prevalence of chronic diseases is also driving the demand for clinical trials, as there is a need for the development of new and efficient therapeutics to treat these diseases. Also, the increased investments in R&D by pharmaceutical and biotechnological companies are driving the growth of the market, as these companies are constantly developing new drugs and therapies that need to be tested in clinical trials.

This category is a moderately fragmented market due to the presence of numerous players. Strategic alliances between pharmaceutical firms and CROs are anticipated to have a substantial impact on the category’s expansion. Additionally, the swift uptake of new technology for better healthcare contributes to the market's expansion. For instance,

• In November 2022, Calit Health Services (Israel) and IQVIA (US) announced a collaboration to work on clinical trial delivery. The collaboration will combine Calit's extensive clinical trial experience and IQVIA's global reach and expertise in data analytics.

• In April 2022, Charles River Laboratories, a pharmaceutical company that provides preclinical and clinical laboratory services, acquired Explora BioLabs, a provider of contract vivarium research services. This acquisition will allow Charles River to expand its offerings in the cell and gene therapy space.

• In February 2022, Citeline and Norstella merged to form a new company worth $5 billion. Citeline provides clinical trial management software, while Norstella provides clinical trial supplies and services. The merger of these two companies will allow them to offer a more comprehensive suite of services to pharmaceutical companies, which could help speed up the drug development process and improve patient access to new therapies.

Order your copy of the Clinical Trials Procurement Intelligence Report, 2024 - 2030, published by Grand View Research, to get more details regarding day one, quick wins, portfolio analysis, key negotiation strategies of key suppliers, and low-cost/best-cost sourcing analysis

Technological advancements in this category have revolutionized the drug development process by reducing costs and increasing efficiency. With rising trial expenses, failure rates, and a focus on patient-centric trials, the demand for the technology in clinical trials has surged. The landscape of clinical trials is evolving towards decentralization with the utilization of wearables, mHealth, and real-world evidence (RWE). These disruptive technologies enable small, controlled trials and streamline processes from patient enrollment to medication administration and follow-ups through mobile devices. Pharmaceutical companies are investing heavily in AI and big data analytics to leverage their transformative impact on the R&D process, enhance competitiveness, and facilitate company transformation and agility. Additionally, the integration of wearable devices and remote sample collection offers a safer and more convenient experience for participants, potentially increasing patient enrollment and engagement in future studies.

Defining the price and cost of this category is complex as it is dependent on various factors like phase, drug type, and location. Costs range from millions to billions, divided into patient care and research costs. Patient care costs include recruitment, enrollment, medication, safety monitoring, while research costs cover design, implementation, data analysis, and results publication. When budgeting for a clinical trial, consider various cost segments like regulatory, safety, data, quality management, overhead, and site costs. The price of this category is determined by the trial sponsor, typically a pharmaceutical company. Various factors can influence the trial's price, including its scale, complexity, and associated risks. Sponsors take these factors into account when setting the price, as they impact the resources required to conduct a successful trial.

When it comes to sourcing of this category, it is crucial to follow the best practices to ensure the high quality and integrity of the study. These practices include identifying reputable trial sites, evaluating investigator qualifications, prioritizing patient safety, assessing site capabilities, reviewing ethical considerations, evaluating data management systems, monitoring compliance with regulations, conducting site visits and audits. Additionally, it is essential to prioritize suppliers who offer comprehensive documentation, including certificates of analysis and trials conducted. By following these best practices, sponsors can enhance the quality, reliability, and ethical standards of their clinical trials. Finally, considering suppliers who engage in continuous research and development efforts can be beneficial for this category.

Clinical Trials Procurement Intelligence Report scope

• Clinical Trials Category Growth Rate: CAGR of 6.49% from 2024 to 2030

• Pricing Growth Outlook: 2% - 3% (Annually)

• Pricing Models: Unit-based pricing

• Supplier Selection Scope: Cost and pricing, Past engagements, Productivity, Geographical presence

• Supplier selection criteria: Reviewing ethical considerations, prioritizing patient safety, regulatory standards and mandates, category innovations, and others

• Report Coverage: Revenue forecast, supplier ranking, supplier matrix, emerging technology, pricing models, cost structure, competitive landscape, growth factors, trends, engagement, and operating model

Browse through Grand View Research’s collection of procurement intelligence studies:

• Clinical IT Services Procurement Intelligence Report, 2023 - 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)

• Clinical Staffing Services Procurement Intelligence Report, 2023 - 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)

Key companies profiled

• IQVIA

• PAREXEL International Corporation

• Pharmaceutical Product Development

• Charles River Laboratory

• ICON Plc

• Syneos Health

• Chiltern International Ltd

• Eli Lilly and Company

• Pfizer

• Caidya

Brief about Pipeline by Grand View Research:

A smart and effective supply chain is essential for growth in any organization. Pipeline division at Grand View Research provides detailed insights on every aspect of supply chain, which helps in efficient procurement decisions.

Our services include (not limited to):

• Market Intelligence involving – market size and forecast, growth factors, and driving trends

• Price and Cost Intelligence – pricing models adopted for the category, total cost of ownerships

• Supplier Intelligence – rich insight on supplier landscape, and identifies suppliers who are dominating, emerging, lounging, and specializing

• Sourcing / Procurement Intelligence – best practices followed in the industry, identifying standard KPIs and SLAs, peer analysis, negotiation strategies to be utilized with the suppliers, and best suited countries for sourcing to minimize supply chain disruptions

[tamanna31]

Digital Health Market Segmentation, Parameters and Prospects 2024 to 2030 Industry Research Report

Digital Health Industry Overview

The global digital health market size was estimated at USD 240.9 billion in 2023 and is projected to grow at a compound annual growth (CAGR) of 21.9% from 2024 to 2030. The market is driven by several factors, such as a strong domestic market for telehealthcare platform developers, mHealth app providers, wearable device manufacturers, and e-prescription systems.

Moreover, the healthcare industry exhibits high growth potential for the IT industry due to supportive government initiatives across all regions. The growing trend of preventive healthcare & the rise in funding for mHealth startups are other factors boosting the market.

Gather more insights about the market drivers, restrains and growth of the Digital Health Market

The rising incidence of chronic conditions such as diabetes, heart disease, and cancer is fueling the demand for remote monitoring and management solutions. Digital health tools can help patients track their health, adhere to treatment plans, and communicate with healthcare providers more effectively.

Global Digital Health Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the segments from 2018 to 2030. For this study, Grand View Research, Inc. has segmented the global digital health market report on the basis of technology, component, application, end-use, and region:

Technology Outlook (Revenue, USD Million, 2018 - 2030)

Tele-healthcare

Tele-care

Activity Monitoring

Remote Medication Management

Tele-health

LTC Monitoring

Video Consultation

mHealth

Wearables & Connected Medical Devices

Vital Sign Monitoring Devices

Heart Rate Monitors

Activity Monitors

Electrocardiographs

Pulse Oximeters

Spirometers

Blood Pressure Monitors

Others

Sleep Monitoring Devices

Sleep trackers

Wrist Actigraphs

Polysomnographs

Others

Electrocardiographs Fetal & Obstetric Devices

Neuromonitoring Devices

Electroencephalographs

Electromyographs

Others

mHealth Apps

Medical Apps

Women's Health

Fitness & Nutrition

Menstrual Health

Pregnancy Tracking & Postpartum Care

Menopause

Disease Management

Others

Chronic Disease Management Apps

Diabetes Management Apps

Blood Pressure & ECG Monitoring Apps

Mental Health Management Apps

Cancer Management Apps

Obesity Management Apps

Other Chronic Disease Management Apps

Personal Health Record Apps

Medication Management Apps

Diagnostic Apps

Remote Monitoring Apps

Others (Pill Reminder, Medical Reference, Professional Networking, Healthcare Education)

Fitness Apps

Services

Monitoring Services

Independent Aging Solutions

Chronic Disease Management & Post-Acute Care Services

Diagnosis Services

Healthcare Systems Strengthening Services

Others

Digital Health Systems

EHR

E-prescribing Systems

Healthcare Analytics

Component Outlook (Revenue, USD Million, 2018 - 2030)

Software

Hardware

Services

Application Outlook (Revenue, USD Million, 2018 - 2030)

Obesity

Diabetes

Cardiovascular

Respiratory Diseases

Others

End-use Outlook (Revenue, USD Million, 2018 - 2030)

Patients

Providers

Payers

Others

Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Sweden

Denmark

Norway

Asia Pacific

China

India

Japan

Australia

South Korea

Singapore

Latin America

Brazil

Mexico

Argentina

MEA

South Africa

Saudi Arabia

UAE

Kuwait

Browse through Grand View Research's Healthcare IT Industry Research Reports.

• The global computerized physician order entry market size was valued at USD 1.94 billion in 2023 and is projected to grow at a CAGR of 6.3% from 2024 to 2030.

• The global healthcare cloud computing market size was valued at USD 19.6 billion in 2023 and is projected to grow at a CAGR of 12.7% from 2024 to 2030.

Key Digital Health Company Insights

Key players are adopting new product development, partnership, and merger & acquisition strategies to increase their market share. Apple, Inc., Google, Inc., and Qualcomm Technologies, Inc. are market leaders with a presence in more than 30 countries, including headquarters, manufacturing sites, distribution centers, and office locations. The Apple App Store features over 40,000 apps in the healthcare segment. In March 2023, to improve digital health, Apple Inc. announced plans to upgrade AirPods by adding ambient light sensors with health tracking features, including motion detectors, temperature monitors, blood oxygen level, and perspiration & heart rate, by 2025. In addition, H2O Therapeutics, a Turkey-based startup, received U.S. FDA clearance for its Parky app. This Apple Watch app monitors Parkinson’s disease symptoms, such as dyskinesia and tremors. Furthermore, Samsung Electronics Co. Ltd., Qualcomm Technologies, Inc., and Vodafone Group Plc. are the emerging market players.

Key Digital Health Companies:

The following are the leading companies in the digital health market. These companies collectively hold the largest market share and dictate industry trends

Telefónica S.A.

Epic Systems Corporation

QSI Management, LLC

AT&T

AirStrip Technologies

Google, Inc.

Hims & Hers Health, Inc.

Orange

Softserve

Computer Programs and Systems, Inc.

Vocera Communications

IBM Corporation

CISCO Systems, Inc.

Apple Inc.

Oracle Cerner

Veradigm

Mckesson Corporation

Hims & Hers Health, Inc.

Vodafone Group

Qualcomm Technologies, Inc.

Samsung Electronics Co., Ltd.

Recent Developments

In April 2023, Microsoft collaborated with Epic Systems Corporation to integrate AI into EHR, enabling healthcare practitioners to improve their productivity and patient communication with AI-enabled solutions

In March 2023, BlueRock Therapeutics LP entered a collaboration with Emerald Innovations and Rune Labs with a major focus on innovations using contactless & invisible, wearable digital health technology to improve monitoring of Parkinson's disease

In March 2023, Google launched Open Health Stack, an open-source program for developers to build health-related apps by including strategies, such as AI partnerships focusing on cancer screening

In March 2023, Nabla Technologies launched Copilot, a digital assistant tool, as a Chrome extension using GPT-3 for doctors to make patients' conversations turn into action

In March 2022, Samsung unveiled its latest innovation, a smart healthcare TV and advanced digital health solutions for healthcare facilities, at the Healthcare Information and Management Systems Society (HIMSS) Global Conference in Florida. Furthermore, Samsung and ShareSafe partnered to develop a secure solution for casting from mobile devices to Samsung Smart Healthcare TV

In March 2022, Epic Systems Corporation launched Garden Plot, which provides small independent healthcare groups access to Epic software solutions and an interoperability network

In March 2022, Vocera Communications, a part of Stryker, introduced Minibadge. This compact, portable, voice-driven wearable device integrates with clinical and operational workflows of healthcare facilities & enables hands-free communication.

Order a free sample PDF of the Digital Health Market Intelligence Study, published by Grand View Research.

[trendtrackershq]

𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐄𝐧𝐠𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰 𝐚𝐧𝐝 𝐆𝐫𝐨𝐰𝐭𝐡 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞: https://www.nextmsc.com/patient-engagement-solutions-market/request-sample

As the healthcare landscape evolves, the 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐄𝐧𝐠𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 is witnessing significant growth and transformation.

𝐊𝐞𝐲 𝐓𝐫𝐞𝐧𝐝𝐬:

𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐜𝐚𝐭𝐢𝐨𝐧: Advanced technologies are enabling more tailored interactions between patients and providers, enhancing satisfaction and compliance.

𝐌𝐨𝐛𝐢𝐥𝐞 𝐇𝐞𝐚𝐥𝐭𝐡 (𝐦𝐇𝐞𝐚𝐥𝐭𝐡) 𝐀𝐩𝐩𝐬: Mobile Health (mHealth) Apps: The rise of mobile applications is making it easier for patients to manage their health, access information, and communicate with healthcare professionals.

𝐃𝐚𝐭𝐚 𝐀𝐧𝐚𝐥𝐲𝐭𝐢𝐜𝐬: Leveraging big data to understand patient behavior and improve engagement strategies is becoming increasingly important.

Telemedicine Integration: The integration of telemedicine platforms with engagement solutions is streamlining access to care and improving patient experiences.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: The global market for Patient Engagement Solutions is expanding rapidly, driven by the increasing demand for improved patient experiences and outcomes. This growth presents opportunities for innovators and investors alike to contribute to a more connected and efficient healthcare system.

𝐋𝐨𝐨𝐤𝐢𝐧𝐠 𝐀𝐡𝐞𝐚𝐝: With continuous advancements in technology and a growing emphasis on patient-centered care, the future of Patient Engagement Solutions is bright. Companies in this space are poised to play a crucial role in shaping the next generation of healthcare delivery.

𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.nextmsc.com/report/patient-engagement-solutions-market

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: The patient engagement solutions industry comprises various key players including Medtronic, Allscripts Healthcare LLC, LG, IBM, Athena Health, Epic Systems Corporations, Press Ganey, Maxim Software Systems, Orion Health, Salesforce, and others.

Let's keep an eye on this exciting market and its potential to transform patient care!

[healthcaremarketanalysis]

Digital Health Market worth $549.7 billion by 2028

The global digital health market, valued at $180.2 billion in 2023, is projected to reach $549.7 billion by 2028, growing at a CAGR of 25.0%. Key factors driving market growth include the increasing penetration of smartphones and mobile platforms, supportive initiatives, strategic alliances, a rising geriatric population, and a focus on patient-centric healthcare solutions. However, high deployment costs and interoperability issues pose challenges. The telehealthcare segment accounted for the largest market share in 2022, driven by demand during the COVID-19 pandemic and improved attitudes towards virtual care. North America holds the largest market share and is expected to grow the fastest due to technological advancements and a favorable regulatory environment. Prominent players in the market include Koninklijke Philips N.V., Medtronic, GE HealthCare, Abbott, and Apple, Inc. Recent developments include Medtronic’s acquisition of EOFlow and GE HealthCare’s partnership with Advantus Health Partners.

Download an Illustrative overview:

"Hardware segment is expected to grow at the highest rate during the forecast period"

Based on offering, the digital health market is segmented into hardware, software, services and applications. In 2022, the hardware segment is expected to grow at the highest CAGR during the forecast period. The highest growth rate is attributed to increased patient demand for convenient healthcare solutions, healthcare provider adoption for improved care and operations, and expansion of telehealth & chronic disease management.

"Telehealthcare technology segment accounted for the largest share of the global digital health market"

Based on technology, the digital health market is segmented into telehealthcare, mHealth, health management solutions and digital therapeutics. The telehealthcare segment accounted for the largest share of the global market in 2022. Factors such as increased demand for remote healthcare services, especially due to the COVID-19 pandemic, accelerated telehealthcare adoption.

"The chronic disease management application segment accounted for the largest share of the digital health industry in 2022"

On the basis of application, the digital health market is segmented into chronic disease management, behavioral health, health & fitness and others. The chronic disease management segment accounted for the largest share of the market in 2022 period, owing to the increasing prevalence of chronic conditions, an aging population, and lifestyle-related health issues.

"Patients & Consumers segment is expected to grow at highest groeth rate in the global digital health market"

On the basis of end user, the digital health market is segmented into providers, payers and patients & consumers. The high growth of this segment is attributed to increasing awareness of self-health management, proliferation of smartphones and wearable devices that has made health tracking and monitoring more accessible and convenient.

North America accounted for the largest share of the global Digital Health Industry in 2022.

The Digital Health market is segmented into four key regions—North America, Europe, APAC, and the Rest of the World (RoW). North America, being the early adopter of advanced technologies, has captured the largest share of the Digital Health market in 2022, followed by Europe and APAC. It is also projected to register the highest CAGR. North America is the fastest-growing regional segment for digital health due to its technological development, expansion in the healthcare industry, favorable regulatory environment, and the presence of key players and innovation hubs.

Request Sample Pages:

Digital Health Market Dynamics:

Drivers

Increasing penetration of smartphones, tablets, and other mobile platforms

Supportive initiatives and increasing strategic alliances

Rising geriatric population and subsequent increase in prevalence of chronic diseases

Rising focus on patient-centric healthcare solutions

 Restraints

High cost of deployment of digital health solutions for small and medium-sized hospitals in emerging countries

Interoperability issues

 Opportunities

Shift toward intelligent health ecosystem to deliver personalized health experiences

Digital health solutions for universal healthcare access

Improving regulatory support and reimbursements

Advancements in digital health

 Challenges

Healthcare gap in emerging economies

Privacy and security concerns

Key Market Players of Digital Health Industry:

Prominent players in the digital health market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE HealthCare (US), Abbott (US), OMRON Corporation (Japan), Fitbit, Inc. (A google company) (US), Johnson & Johnson Private Limited (US), Siemens Healthineers AG (Germany), Masimo (US), Apple, Inc. (US), Merative (US), AT & T, Inc. (US), Veradigm LLC (US), Noom, Inc. (US), Teladoc Health, Inc. (US), Omada Health Inc. (US), Dexcom, Inc. (US), Biotricity (US), iHealth Labs Inc (US), my mhealth Limited (UK), athenahealth (US), eClinicalWorks (US), AirStrip Technologies, Inc (US), AdvancedMD, Inc. (US) and Qardio, Inc. (US). Players adopted organic as well as inorganic growth strategies such as product upgrades, collaborations, agreements, partnerships, and acquisitions to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

Recent Developments:

In May 2023 Medtronic (Ireland) acquired EOFlow Co. Ltd. (South Korea) to expand its ability to treat patients with diabetes.

In March 2023, GE HealthCare (US) partnered with Advantus Health Partners (US) to sign a multi-year contract to expand access to Healthcare Technology Management Services.

In April 2023, Abbott (US) acquired Cardiovascular Systems, Inc. (CSI) (US) to gain a complementary treatment option for vascular illness. The highly advanced atherectomy technology from CSI prepares vessels for angioplasty or stenting to restore blood flow.

Related Links:

[creativeera]

Digital Biomarkers Market is Estimated to Witness High Growth Owing to Rising Demand for Remote Healthcare

The digital biomarkers market has seen significant growth in recent years. Digital biomarkers, also known as biomarkers that are objectively measured and evaluated through digital sensors or records as indicators of a biological state. Some examples of digital biomarkers include heart rate variability, physical activity levels, sleep patterns, typing cadence, and the swipe speed on smartphone screens. The growing adoption of digital health technologies has increased the use of these digital biomarkers. Wearable devices and smartphone apps can track individuals' digital biomarkers and share the information with healthcare providers for remote monitoring of health conditions. Remote monitoring solutions provide convenience to patients and reduce the burden on healthcare systems. The global digital biomarkers market was valued at US$ 2.03 Bn in 2022 and is forecast to reach a value of US$ 22.28 Bn by 2030 at a CAGR of 34.1% between 2023 and 2030.

Key Takeaways Key players operating in the digital biomarkers market are Purina Mills LLC, Nutreco N.V., Roquette Freres S.A., Evonik Industries A G, Charoen Pokphand Foods PLC, Alltech Inc., Associated British Foods Plc., Koninklijke DSM NV, BASF SE, ACI Godrej Agrovet Private Limited. Many of these players are investing in partnerships and acquisitions for product development and portfolio expansion focused on digital solutions. Some of the key opportunities in the market include growing demand for mHealth and remote patient monitoring solutions, increasing adoption of digital biomarkers in clinical trials as well as rising popularity of wearable devices collecting Digital Biomarkers Market Growth . Geographically, North America dominates the global digital biomarkers market due to advancements in digital health technologies and supportive initiatives for digital healthcare in countries like the US. However, Asia Pacific is expected to witness the highest growth rate over the forecast period with increasing adoption of digital health solutions in developing countries like India and China. Market Drivers The increasing demand for remote healthcare monitoring solutions is a key driver boosting the digital biomarkers market. Patients prefer remote monitoring as it saves travel costs and time spent visiting clinicians frequently. This has increased the use of digital biomarkers collected via smartphones and wearables to monitor health conditions remotely. The growing prevalence of chronic diseases worldwide is also driving the need for digital care through effective monitoring of patients. Furthermore, digital biomarkers find applications in clinical trials through digital endpoints and decentralized trials, thereby supporting research activities. Overall, the advent of digital health is transforming care models and favoring the digital biomarkers industry.

PEST Analysis Political: Advancement in digital innovations and acceptance of technologies have paved the way for digital biomarkers market to grow. Governments worldwide are supporting initiatives for remote health monitoring to lower healthcare costs which is fueling the market growth. Economic: Overall growth of healthcare IT sector and growing investment by providers in digital technologies is driving the digital biomarkers market. Adoption of digital tools allows payers and providers to reduce manual documentation tasks and lower operational costs. Social: Increased internet and smartphone penetration are allowing wider acceptance of self monitoring tools. Tech savvy population especially young adults are willing to use digital solutions to track health data and share with doctors for better care. Technological: Availability of low cost sensors, connectivity through apps and cloud storage facilities are major technological factors driving the digital biomarkers market. Advancements in AI, machine learning are making analysis of biomarker data more reliable, swift and easy. The digital biomarkers market in terms of value is concentrated majorly in North America and Western Europe. North America holds the largest share due to strong technical infrastructure and established healthcare industry in the region. Advancements done by the US based companies also aids growth. Asia Pacific is recognized as the fastest growing regional market for digital biomarkers. Rising spending capabilities, growing preventive healthcare approach and increasing prevalence of chronic diseases are driving adoption. Countries like India, China and Japan are focusing on building telehealth platforms to tap growth opportunities. Expanding middle class population and improving connectivity in APAC further supports the market expansion.

Get more insights on Digital Biomarkers Market

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

[tejalbele-2024]

Healthcare IT includes the creation, development, design, and maintenance of information systems for the healthcare industry. The market is experiencing significant growth due to increase in demand for quality healthcare services and solutions, rise in acceptance of mHealth and telehealth practices, surge in demand for improved patient safety and patient care, rise in government initiative to promote HCIT, and increase in adoption of cloud technology in healthcare.

[wellnessweb]

Emerging Trends in mHealth Market Size

The mHealth Market size is expected to reach USD 142.94 Bn by 2031, and the base value of the market was valued at USD 62.93 Bn in 2023. The CAGR growth rate was recorded at 10.81% over the forecast period of 2024-2031.The mHealth market, driven by the convergence of mobile technology and healthcare, continues to expand with unprecedented innovation and accessibility. From remote patient monitoring to personalized health apps, the landscape is defined by its transformative impact on healthcare delivery.

This dynamic sector embraces a spectrum of stakeholders, from tech giants pioneering wearable devices to startups revolutionizing telemedicine platforms. As the demand for real-time health information grows, mHealth's potential to enhance patient outcomes and streamline medical processes becomes increasingly evident. With regulatory frameworks evolving to accommodate these advancements, the mHealth market stands poised at the intersection of digital ingenuity and global health improvement, promising a future where healthcare is both proactive and personalized.

The global market research contains a skill analysis that can be used by both new and established brands. The mHealth Market  research collects a thorough qualitative and quantitative assessment of the target market during the future time in order to assist enterprises in developing globally.

Get Sample Report @ https://www.snsinsider.com/sample-request/3521

Market Segmentation

By Component

Wearables

mHealth Apps

By Participants

Mobile Participants

Device vendors

Content Players

Healthcare Providers

By Services

Monitoring Services

Diagnosis Services

Healthcare Systems

Others

Russia-Ukraine War Impact on mHealth Market

The impact of the Russia-Ukraine conflict on the worldwide market is detailed in the research paper. While tensions between Russia and Ukraine have been increasing for years, the present military action heightens fears of a long-term conflict within Ukraine, as well as market and global economic implications.

Regional Analysis

The global market study was compiled using a thorough market analysis and input from industry experts. The global mHealth Market  research report includes an analysis of the global and regional markets, as well as applications, definitions, and manufacturing technologies. The research study also includes a comprehensive statistical analysis and in-depth investigation of the market from a worldwide viewpoint, covering profit, cost, demand, and supply.

Competitive Scenario

The global market analysis also includes a market landscape and a number of possible prospects for the projection period. The leading service providers in the global market are also examined in this study. The market also looks at the top companies' primary growth strategies. This research also looks at the market potential and recent trends in the target industry. The research looks on the major competitors in the mHealth Market .

Pricing, interview records, gross profit, shipping, revenue, and firm distribution are all included in the market analysis, allowing clients to get a better image of the global competitive landscape. mHealth Market  research also provides in-depth analysis of a variety of themes, ranging from current events to future trends.

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in re framing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Nasal Drug Delivery Market Growth Drivers

DNA Synthesis Market Growth Drivers

Osteoporosis Treatment Market Growth Drivers

Immunomodulators Market Growth Drivers

Proteomics Market Growth Drivers

[techninja]

Digital Health Market: Revolutionizing Healthcare in the 21st Century

The digital health market is experiencing an unprecedented transformation, fueled by rapid advancements in technology, increasing internet penetration, and the growing demand for innovative healthcare solutions. This article delves into the intricate details of the digital health market, exploring its current landscape, key drivers, emerging trends, and future prospects. As we navigate through this comprehensive overview, we aim to provide valuable insights that can help stakeholders make informed decisions and harness the potential of digital health.

Understanding the Digital Health Market

The digital health market encompasses a broad spectrum of technologies and services designed to improve healthcare delivery, enhance patient outcomes, and reduce costs. These include telemedicine, mobile health (mHealth) applications, wearable devices, health information technology (IT), and personalized medicine.

Key Components of the Digital Health Ecosystem

Telemedicine: Telemedicine involves the remote diagnosis and treatment of patients through telecommunications technology. It enables healthcare providers to deliver care to patients in remote or underserved areas, reducing the need for physical visits and enhancing access to medical expertise.

Mobile Health (mHealth): mHealth refers to the use of mobile devices, such as smartphones and tablets, to support health and wellness. This includes health apps for monitoring vital signs, medication adherence, fitness tracking, and chronic disease management.

Wearable Devices: Wearable health devices, such as smartwatches and fitness trackers, collect real-time data on various health metrics, including heart rate, activity levels, sleep patterns, and more. These devices empower individuals to take proactive steps towards maintaining their health.

Health Information Technology (IT): Health IT encompasses electronic health records (EHRs), health information exchanges (HIEs), and other digital tools that facilitate the secure sharing and analysis of health data. This improves care coordination, reduces medical errors, and enhances patient safety.

Personalized Medicine: Personalized medicine leverages genetic and molecular data to tailor medical treatments to individual patients. This approach promises more effective and targeted therapies, minimizing adverse effects and improving patient outcomes.

Driving Forces Behind the Digital Health Market Growth

Several factors are propelling the growth of the digital health market:

Technological Advancements: Innovations in artificial intelligence (AI), big data analytics, blockchain, and the Internet of Things (IoT) are revolutionizing digital health. These technologies enable the development of sophisticated diagnostic tools, predictive analytics, and secure health data management systems.

Rising Healthcare Costs: The escalating costs of healthcare services are driving the adoption of digital health solutions that can improve efficiency, reduce waste, and lower expenses. Telemedicine, for example, can significantly cut costs associated with in-person visits.

Aging Population: The global aging population is leading to an increased prevalence of chronic diseases and a higher demand for healthcare services. Digital health technologies offer innovative ways to manage chronic conditions and support elderly care.

Consumer Demand for Convenience: Patients are increasingly seeking convenient and accessible healthcare options. Digital health solutions, such as telehealth and mHealth apps, cater to this demand by providing on-the-go access to medical advice and services.

Government Initiatives and Policies: Governments worldwide are promoting the adoption of digital health technologies through funding, incentives, and regulatory support. These initiatives aim to improve healthcare accessibility, quality, and sustainability.

Emerging Trends in the Digital Health Market

The digital health market is evolving rapidly, with several key trends shaping its future:

Artificial Intelligence and Machine Learning: AI and machine learning are transforming digital health by enabling predictive analytics, automated diagnosis, and personalized treatment plans. AI-powered chatbots and virtual health assistants are also enhancing patient engagement and support.

Telehealth Expansion: The COVID-19 pandemic has accelerated the adoption of telehealth services, leading to a permanent shift in how healthcare is delivered. Telehealth platforms are expanding their capabilities to include virtual consultations, remote monitoring, and telepharmacy services.

Integration of Wearables with Health IT: The integration of wearable devices with health IT systems allows for continuous monitoring of patients' health and seamless sharing of data with healthcare providers. This integration enhances preventive care and early intervention.

Blockchain for Health Data Security: Blockchain technology is being explored to enhance the security and privacy of health data. Its decentralized and immutable nature ensures secure and transparent data transactions, reducing the risk of data breaches.

Patient-Centric Healthcare: The shift towards patient-centric healthcare emphasizes the importance of patient engagement, empowerment, and personalized care. Digital health solutions are enabling patients to take an active role in managing their health and making informed decisions.

Challenges and Opportunities in the Digital Health Market

While the digital health market presents numerous opportunities, it also faces several challenges:

Data Privacy and Security: The increasing digitization of health data raises concerns about privacy and security. Ensuring robust data protection measures and compliance with regulations, such as HIPAA and GDPR, is critical.

Interoperability: The lack of interoperability between different digital health systems can hinder the seamless exchange of health data. Efforts to establish common standards and protocols are essential to overcome this barrier.

Regulatory Hurdles: Navigating the complex regulatory landscape of digital health can be challenging for companies. Clear and consistent regulatory frameworks are needed to facilitate innovation and ensure patient safety.

Digital Divide: Disparities in access to digital health technologies persist, particularly in low-income and rural areas. Bridging the digital divide is crucial to ensure equitable access to healthcare services.

Adoption and Usability: Ensuring that digital health solutions are user-friendly and meet the needs of both patients and healthcare providers is vital for widespread adoption. Continuous user feedback and iterative design improvements are key to success.

Future Outlook of the Digital Health Market

The future of the digital health market looks promising, with continued growth and innovation on the horizon. Key areas of focus include:

Advanced Analytics and Personalized Care: The use of advanced analytics and AI will further enhance personalized care, enabling precise diagnostics and tailored treatments based on individual health profiles.

Expansion of Telehealth Services: Telehealth will continue to expand, integrating with other digital health technologies to provide comprehensive and coordinated care. Virtual reality (VR) and augmented reality (AR) may also play a role in future telehealth applications.

Enhanced Remote Monitoring: Remote monitoring technologies will evolve to offer more sophisticated and accurate health tracking. This will be particularly beneficial for managing chronic conditions and post-acute care.

Global Collaboration and Partnerships: Collaboration between healthcare providers, technology companies, and governments will drive innovation and the adoption of digital health solutions. Public-private partnerships and international cooperation will be key to addressing global health challenges.

Sustainable Healthcare Models: Digital health technologies will contribute to the development of sustainable healthcare models that prioritize preventive care, efficient resource utilization, and improved patient outcomes.

The digital health market is set to revolutionize healthcare, offering innovative solutions that enhance accessibility, efficiency, and quality of care. By embracing these technologies and addressing the associated challenges, we can pave the way for a healthier future.

[market-insider]

Global Expansion Strategies in Digital Health Market

The global digital health market size is anticipated to reach USD 946.0 billion by 2030 and it is projected to grow at a CAGR of 21.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth driven by various factors. These include the proliferation of smartphones, advancements in internet connectivity, the development of IT infrastructure, increasing healthcare IT expenditures, overburdened healthcare facilities, a growing shortage of healthcare providers, rising demand for remote patient monitoring services, escalating medical costs, improved accessibility of virtual care services, and the increasing prevalence of chronic diseases. This growth is further propelled by the ongoing trend of digitalization in healthcare. This trend finds support in expanding public-private partnerships, emerging startups in the healthcare sector, and favorable initiatives undertaken by governments to promote digital health solutions.

Digital Health Market Report Highlights

Based on component, the services segment accounted for largest revenue share in 2023, owing to the growing demand for services, such as installation, staffing, training, maintenance, and other services

Based on technology, the tele-healthcare segment led the market with the largest revenue share of 43.2% in 2023, due to increasing preference for remote patient monitoring services and shortage of healthcare professionals

Based on the application, the diabetes segment led the market with the largest share of 24.3% in 2023 and is expected to register the fastest CAGR over the forecast period. The obesity segment is the second largest in applications of the digital health market

Based on the end-use, the patient segment held the largest market share of 34.1% in 2023 and is expected to witness the fastest CAGR during the forecast period

North America dominated the market with a revenue share of 38.2% in 2023 due to the rapidly developing healthcare IT infrastructure, emergence of startups, growing funding options, and improving technological literacy

For More Details or Sample Copy please visit link @: Digital Health Market Report

Digital health encompasses diverse technologies such as telehealth services, health information technology, and mobile health (mHealth) to enhance communication within healthcare systems, fostering improved interactions between doctors and patients. The relevance of digital health technology has grown significantly, especially during the COVID-19 pandemic. These contemporary solutions enhance the patient-doctor relationship and extend preventive disease strategies. Furthermore, they contribute to a shift in healthcare towards value-based treatment, amplifying the accessibility of health information for both patients and healthcare providers.

Furthermore, integrating wearable devices into healthcare reshapes how individuals manage their health. Wearables like fitness trackers and smartwatches enable continuous monitoring of vital signs, physical activity, and other health metrics. This real-time data empowers individuals to take a proactive role in their well-being and allows healthcare providers to offer personalized preventive care. Companies such as Apple and Fitbit exemplify the success of wearables in the digital health market, emphasizing the fusion of technology and health monitoring.

Many nations have adopted telemedicine, remote monitoring platforms, and telehealth services to enable physical interactions among physicians and the patient population. Therefore, digital health industry experienced a boost in terms of revenue in 2020-2021 and is expected to maintain an upward trajectory in the projected technology life cycle. For instance, MyDoc, a telehealth platform headquartered in Singapore, witnessed a 160% growth in daily active users in 2020. Government initiatives to promote global digitalization in the healthcare sector are playing a significant role in propelling the market’s growth. For instance, in the 2022 budget session, the Government of India launched a digital health ecosystem as part of the Ayushman Bharat Digital Health Mission (ABDM). In October 2021, the French government revealed plans to invest over USD 650 million to enhance its digital health infrastructure nationally.

The digital health industry is a dynamic space where both established entities and startups compete for prominence, driven by the prospect of improving healthcare accessibility, affordability, and outcomes. Tech and healthcare giants are making ventures into this industry, coexisting with emerging local startups that address specific regional needs, attracting global investment. The growth of AI-powered solutions for patient monitoring and personalized care is evident, with the increasing involvement of healthcare professionals in their development and adoption. Moreover, various players are actively adopting strategies such as mergers, acquisitions, collaboration, partnerships, and product launches to maintain a competitive edge. For instance, in July 2023, Epic Systems Corporation collaborated with Nuance Communications, Inc., a Microsoft Company, to develop the Nuance Dragon Ambient eXperience (DAX) Express solution, which expands access to care for patients and enhances healthcare outcomes. Additionally, in December 2022, Greenway Health, LLC. Launched the Greenway Engagement Model, a client engagement program, to strengthen the healthcare technology journey of its clients.

List of Key Players in Digital Health Market

Telefónica S.A.

Epic Systems Corporation

QSI Management, LLC

AT&T

AirStrip Technologies

Google, Inc.

Hims & Hers Health, Inc.

Orange

Softserve

Computer Programs and Systems, Inc.

Gain deeper insights on the market and receive your free copy with TOC now @: Digital Health Market Report

We have segmented the global digital health market based on technology, component, application, end-use, and region.

Research Methodology

We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S. based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Contact:

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll-Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Explore Horizon, the world's most expansive market research database

[health-views-updates]

2024 MicroRNA Market Outlook: Future Trends and Insights

MicroRNA Market Outlook, Scope & Overview:

Industry reports indicate that the global microRNA market was valued at USD 1.57 billion in 2023 and is projected to reach USD 4.13 billion by 2031, growing at a CAGR of 12.88% over the forecast period 2024-2031.

Technological Advancements to Drive Growth of Global MicroRNA Market

The adoption of advanced microRNA (miRNA) technologies will continue to influence global market revenues. Researchers and healthcare professionals are increasingly utilizing miRNA for its potential in diagnostics, therapeutics, and disease monitoring.

As a product segment, miRNA therapeutics currently hold a significant share of the global microRNA market. This segment is anticipated to grow at a year-over-year rate of 12.88% in 2024 over 2023 and reach USD 4.13 billion in revenues by 2031. The increasing demand for precision medicine and the growing understanding of miRNA's role in gene expression regulation are expected to drive market growth.

Get a Free Sample Report: https://www.snsinsider.com/sample-request/3143 

MicroRNA Solutions – Market Dynamics

Drivers:

MicroRNA solutions are witnessing significant growth in the global market due to their potential in treating various diseases, including cancer, cardiovascular diseases, and neurological disorders. The advancements in miRNA research, coupled with the increasing investment in biotechnology and pharmaceutical R&D, are key factors driving the adoption of miRNA solutions worldwide. Additionally, the rising prevalence of chronic diseases and the growing need for early diagnosis and targeted therapies are further propelling market growth.

Restraints:

Despite the growth potential, challenges such as the complexity of miRNA-based therapies, regulatory hurdles, and the high cost of miRNA research and development are hindering the widespread adoption of miRNA solutions. Moreover, the lack of standardized protocols and the need for robust clinical validation pose additional challenges to market expansion.

MicroRNA Solutions – Market Outlook

The proven benefits of microRNA solutions in disease diagnosis, treatment, and monitoring have contributed to the market's growth. MicroRNA solutions are expected to witness increased adoption across major markets, including North America, Europe, and Asia Pacific, driven by advancements in biotechnology and the growing focus on personalized medicine.

Global MicroRNA Market

The rise in demand for microRNA solutions in developed and emerging markets is expected to drive market growth over the forecast period. North America currently holds a significant market share in the global microRNA market, with the US being a key contributor to market revenues. Europe and Asia Pacific regions are also experiencing rapid adoption of miRNA solutions, supported by favorable regulatory frameworks and increasing investments in biotechnology research.

Key Players in the MicroRNA Solutions Market

Leading companies in the microRNA solutions market include Thermo Fisher Scientific, Qiagen N.V., Agilent Technologies, and Bio-Rad Laboratories. These companies are at the forefront of developing and commercializing advanced miRNA technologies for various applications, including diagnostics, therapeutics, and research.

In conclusion, the global microRNA market is poised for substantial growth over the forecast period, driven by technological advancements, increasing R&D investments, and the expanding adoption of miRNA solutions in precision medicine and targeted therapies.

Other Trending Reports

Medical Aesthetics Industry Growth

Risk-based Monitoring Software Industry Growth

Healthcare Contract Research Organization Industry Growth

mHealth Industry Growth

[adityarana1687-blog]

Digital Health Market Size To Reach $946.0 Billion By 2030

The global digital health market size is anticipated to reach USD 946.0 billion by 2030 and it is projected to grow at a CAGR of 21.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth driven by various factors. These include the proliferation of smartphones, advancements in internet connectivity, the development of IT infrastructure, increasing healthcare IT expenditures, overburdened healthcare facilities, a growing shortage of healthcare providers, rising demand for remote patient monitoring services, escalating medical costs, improved accessibility of virtual care services, and the increasing prevalence of chronic diseases. This growth is further propelled by the ongoing trend of digitalization in healthcare. This trend finds support in expanding public-private partnerships, emerging startups in the healthcare sector, and favorable initiatives undertaken by governments to promote digital health solutions.

Digital health encompasses diverse technologies such as telehealth services, health information technology, and mobile health (mHealth) to enhance communication within healthcare systems, fostering improved interactions between doctors and patients. The relevance of digital health technology has grown significantly, especially during the COVID-19 pandemic. These contemporary solutions enhance the patient-doctor relationship and extend preventive disease strategies. Furthermore, they contribute to a shift in healthcare towards value-based treatment, amplifying the accessibility of health information for both patients and healthcare providers.

Furthermore, integrating wearable devices into healthcare reshapes how individuals manage their health. Wearables like fitness trackers and smartwatches enable continuous monitoring of vital signs, physical activity, and other health metrics. This real-time data empowers individuals to take a proactive role in their well-being and allows healthcare providers to offer personalized preventive care. Companies such as Apple and Fitbit exemplify the success of wearables in the digital health market, emphasizing the fusion of technology and health monitoring.

Many nations have adopted telemedicine, remote monitoring platforms, and telehealth services to enable physical interactions among physicians and the patient population. Therefore, digital health industry experienced a boost in terms of revenue in 2020-2021 and is expected to maintain an upward trajectory in the projected technology life cycle. For instance, MyDoc, a telehealth platform headquartered in Singapore, witnessed a 160% growth in daily active users in 2020. Government initiatives to promote global digitalization in the healthcare sector are playing a significant role in propelling the market’s growth. For instance, in the 2022 budget session, the Government of India launched a digital health ecosystem as part of the Ayushman Bharat Digital Health Mission (ABDM). In October 2021, the French government revealed plans to invest over USD 650 million to enhance its digital health infrastructure nationally.

The digital health industry is a dynamic space where both established entities and startups compete for prominence, driven by the prospect of improving healthcare accessibility, affordability, and outcomes. Tech and healthcare giants are making ventures into this industry, coexisting with emerging local startups that address specific regional needs, attracting global investment. The growth of AI-powered solutions for patient monitoring and personalized care is evident, with the increasing involvement of healthcare professionals in their development and adoption. Moreover, various players are actively adopting strategies such as mergers, acquisitions, collaboration, partnerships, and product launches to maintain a competitive edge. For instance, in July 2023, Epic Systems Corporation collaborated with Nuance Communications, Inc., a Microsoft Company, to develop the Nuance Dragon Ambient eXperience (DAX) Express solution, which expands access to care for patients and enhances healthcare outcomes. Additionally, in December 2022, Greenway Health, LLC. Launched the Greenway Engagement Model, a client engagement program, to strengthen the healthcare technology journey of its clients.

Request a free sample copy or view report summary: Digital Health Market Report

Digital Health Market Report Highlights

Based on component, the services segment accounted for largest revenue share in 2023, owing to the growing demand for services, such as installation, staffing, training, maintenance, and other services

Based on technology, the tele-healthcare segment led the market with the largest revenue share of 43.2% in 2023, due to increasing preference for remote patient monitoring services and shortage of healthcare professionals

Based on the application, the diabetes segment led the market with the largest share of 24.3% in 2023 and is expected to register the fastest CAGR over the forecast period. The obesity segment is the second largest in applications of the digital health market

Based on the end-use, the patient segment held the largest market share of 34.1% in 2023 and is expected to witness the fastest CAGR during the forecast period

North America dominated the market with a revenue share of 38.2% in 2023 due to the rapidly developing healthcare IT infrastructure, emergence of startups, growing funding options, and improving technological literacy

Digital Health Market Segmentation

Grand View Research has segmented the global digital health market based on technology, component, application, end-use, and region:

Technology Outlook (Revenue, USD Million, 2018 - 2030)

Tele-healthcare

Tele-care

Activity Monitoring

Remote Medication Management

Tele-health

LTC Monitoring

Video Consultation

mHealth

Wearables & Connected Medical Devices

Vital Sign Monitoring Devices

Heart Rate Monitors

Activity Monitors

Electrocardiographs

Pulse Oximeters

Spirometers

Blood Pressure Monitors

Others

Sleep Monitoring Devices

Sleep trackers

Wrist Actigraphs

Polysomnographs

Others

Electrocardiographs Fetal & Obstetric Devices

Neuromonitoring Devices

Electroencephalographs

Electromyographs

Others

mHealth Apps

Medical Apps

Women's Health

Fitness & Nutrition

Menstrual Health

Pregnancy Tracking & Postpartum Care

Menopause

Disease Management

Others

Chronic Disease Management Apps

Diabetes Management Apps

Blood Pressure & ECG Monitoring Apps

Mental Health Management Apps

Cancer Management Apps

Obesity Management Apps

Other Chronic Disease Management Apps

Personal Health Record Apps

Medication Management Apps

Diagnostic Apps

Remote Monitoring Apps

Others (Pill Reminder, Medical Reference, Professional Networking, Healthcare Education)

Fitness Apps

Services

Monitoring Services

Independent Aging Solutions

Chronic Disease Management & Post-Acute Care Services

Diagnosis Services

Healthcare Systems Strengthening Services

Others

Digital Health Systems

EHR

E-prescribing Systems

Healthcare Analytics

Component Outlook (Revenue, USD Million, 2018 - 2030)

Software

Hardware

Services

Application Outlook (Revenue, USD Million, 2018 - 2030)

Obesity

Diabetes

Cardiovascular

Respiratory Diseases

Others

End-use Outlook (Revenue, USD Million, 2018 - 2030)

Patients

Providers

Payers

Others

Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Europe

UK

Germany

France

Italy

Spain

Sweden

Denmark

Norway

Asia Pacific

China

India

Japan

Australia

South Korea

Singapore

Latin America

Brazil

Mexico

Argentina

MEA

South Africa

Saudi Arabia

UAE

Kuwait

List of Key Players in Digital Health Market

Telefónica S.A.

Epic Systems Corporation

QSI Management, LLC

AT&T

AirStrip Technologies

Google, Inc.

Hims & Hers Health, Inc.

Orange

Softserve

Computer Programs and Systems, Inc.

Vocera Communications

IBM Corporation

CISCO Systems, Inc.

Apple Inc.

Oracle Cerner

Veradigm

Mckesson Corporation

Hims & Hers Health, Inc.

Vodafone Group

Qualcomm Technologies, Inc.

Samsung Electronics Co., Ltd

Contact Us -  https://www.grandviewresearch.com/horizon 

[trendtrackershq]

Asia-Pacific: A Rising Giant - Poised for Dominance in the Point-of-Care Glucose Testing Market by 2030

Introduction:

The Point-of-Care Glucose Testing Market is experiencing a global surge, driven by the rising diabetes epidemic and the increasing demand for convenient and self-monitoring blood sugar management tools. While North America currently holds the dominant market share, the Asia-Pacific (APAC) region is emerging as a strong contender, poised for significant growth in the coming years.

Download FREE Sample: https://www.nextmsc.com/point-of-care-glucose-testing-market/request-sample

A Growing Diabetes Burden: Fueling Demand for POC Testing

The APAC region faces a significant challenge with a rapidly rising diabetes burden. According to the International Diabetes Federation (IDF), the APAC region is home to over half of the world's diabetic population, with China and India leading the charge [Source 2]. This alarming statistic underscores the urgent need for accessible and efficient blood sugar monitoring solutions, making POC glucose testing devices highly sought-after in the region.

Factors Driving Growth in the APAC POC Glucose Testing Market:

Several key factors are contributing to the exponential growth of the APAC POC glucose testing market:

Rising Disposable Incomes and Growing Awareness: The economic growth witnessed in several APAC countries is leading to increased disposable incomes. This, coupled with growing awareness about diabetes and its management, is creating a favorable environment for the adoption of POC glucose testing devices.

Expanding Healthcare Infrastructure and Government Initiatives: Governments in the APAC region are making significant investments in expanding healthcare infrastructure, particularly in rural and remote areas. Additionally, several governments are implementing initiatives to promote diabetes screening and early detection. These initiatives often include promoting the use of POC glucose testing devices for effective self-monitoring.

Focus on Affordable and Accessible Technologies: Manufacturers are increasingly developing cost-effective POC glucose testing devices specifically tailored for the needs of the APAC market. This focus on affordability, alongside initiatives promoting access to these devices, is crucial for reaching a wider population in the region.

Technological Advancements and Mobile Health Integration: The APAC region is witnessing a rapid rise in mobile phone adoption and internet penetration. This opens doors for the integration of POC glucose testing devices with mobile health (mHealth) applications. These apps allow for data tracking, analysis, and remote consultations with healthcare providers, further enhancing the appeal and effectiveness of POC testing in the region.

Rise of Big Data and Analytics:  The vast amount of data generated by POC glucose testing devices, coupled with big data analytics, can provide valuable insights into diabetes trends and personalized treatment plans. This trend is likely to drive the adoption of POC devices with data connectivity capabilities in the APAC region.

Focus on Artificial Intelligence (AI) Integration:  Advancements in AI hold immense potential for the POC glucose testing market. AI-powered algorithms can analyze blood sugar data and identify trends, predict potential complications, and even offer personalized recommendations for diabetes management. This integration of AI with POC devices is expected to gain traction in the APAC region.

Growing Telehealth Adoption:  The APAC region is witnessing a surge in telehealth adoption, driven by factors like increasing internet penetration and a shortage of healthcare professionals, particularly in rural areas. POC glucose testing devices that seamlessly integrate with telehealth platforms can empower patients in remote locations to receive timely consultations and guidance from healthcare providers.

Emphasis on Preventative Healthcare:  The growing awareness of the long-term complications associated with diabetes is shifting the focus towards preventative healthcare in the APAC region. POC glucose testing devices play a crucial role in enabling early detection of diabetes and promoting self-management practices, contributing to a preventative healthcare approach.

Challenges and Opportunities in the APAC Market:

Despite its immense potential, the APAC POC glucose testing market faces some challenges:

Uneven Healthcare Infrastructure: Healthcare infrastructure development varies considerably across the APAC region. While some countries boast advanced medical facilities, others struggle with limited resources and accessibility, particularly in rural areas. Addressing this disparity is crucial for ensuring equitable access to POC testing devices.

Limited Reimbursement Policies: Reimbursement policies for POC glucose testing devices can be complex and vary depending on individual countries and healthcare providers. Streamlining these policies could significantly increase patient access to these devices.

Inquire before buying: https://www.nextmsc.com/point-of-care-glucose-testing-market/inquire-before-buying

Looking Ahead: A Future of Innovation and Accessibility

The APAC region is on track to become a dominant force in the POC glucose testing market. With its large and growing diabetic population, rising disposable incomes, and increasing government support, the demand for these devices is expected to surge in the coming years. However, addressing the challenges of uneven healthcare infrastructure and limited reimbursement is crucial for ensuring equitable access and maximizing the impact of POC testing in the region. By fostering innovation in affordable and accessible technologies, coupled with improved healthcare infrastructure and supportive policies, the APAC region can leverage POC glucose testing devices to empower patients with diabetes and achieve better health outcomes.

Conclusion:

The APAC region stands poised to become a leader in the global point-of-care glucose testing market. Driven by a rapidly rising diabetic population, increasing disposable incomes, and supportive government initiatives, the demand for these devices is projected to soar. Several factors contribute to this growth, including a focus on affordable and accessible technologies, the integration with mobile health (mHealth) applications, and the rise of big data and AI for personalized diabetes management. Furthermore, the growing adoption of telehealth and the emphasis on preventative healthcare in the APAC region further incentivize the use of POC glucose testing devices. However, challenges remain. Uneven healthcare infrastructure and limited reimbursement policies can create barriers to access, particularly in rural areas. Addressing these disparities is crucial for maximizing the impact of POC testing and ensuring equitable access for all.

[healthcaremarketanalysis]

Digital Health Market Size, Share, Trends and Revenue Forecast [2028]

 Digital Health Market in terms of revenue was estimated to be worth $180.2 billion in 2023 and is poised to reach $549.7 billion by 2028, growing at a CAGR of 25.0% from 2023 to 2028 according to a new report by MarketsandMarkets. The growth of this market is driven by the expansion of telemedicine and telehealth services, enhanced patient engagement and empowerment and increased investment in health tech startups. On the other hand, variability in healthcare infrastructure and digital literacy, reimbursement and payment issues are some of the factors challenging the growth of the market.

Download an Illustrative overview:

Browse in-depth TOC on "Digital Health Market"

231 - Tables

49 - Figures

301 – Pages

North America accounted for the largest share of the global Digital Health Industry in 2022.

The Digital Health market is segmented into four key regions—North America, Europe, APAC, and the Rest of the World (RoW). North America, being the early adopter of advanced technologies, has captured the largest share of the Digital Health market in 2022, followed by Europe and APAC. It is also projected to register the highest CAGR. North America is the fastest-growing regional segment for digital health due to its technological development, expansion in the healthcare industry, favorable regulatory environment, and the presence of key players and innovation hubs.

Request Sample Pages:

Digital Health Market Dynamics:

Drivers

·         Increasing penetration of smartphones, tablets, and other mobile platforms

·         Supportive initiatives and increasing strategic alliances

·         Rising geriatric population and subsequent increase in prevalence of chronic diseases

·         Rising focus on patient-centric healthcare solutions

 Restraints

·         High cost of deployment of digital health solutions for small and medium-sized hospitals in emerging countries

·         Interoperability issues

 Opportunities

·         Shift toward intelligent health ecosystem to deliver personalized health experiences

·         Digital health solutions for universal healthcare access

·         Improving regulatory support and reimbursements

·         Advancements in digital health

 Challenges

·         Healthcare gap in emerging economies

·         Privacy and security concerns

Key Market Players of Digital Health Industry:

Prominent players in the digital health market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE HealthCare (US), Abbott (US), OMRON Corporation (Japan), Fitbit, Inc. (A google company) (US), Johnson & Johnson Private Limited (US), Siemens Healthineers AG (Germany), Masimo (US), Apple, Inc. (US), Merative (US), AT & T, Inc. (US), Veradigm LLC (US), Noom, Inc. (US), Teladoc Health, Inc. (US), Omada Health Inc. (US), Dexcom, Inc. (US), Biotricity (US), iHealth Labs Inc (US), my mhealth Limited (UK), athenahealth (US), eClinicalWorks (US), AirStrip Technologies, Inc (US), AdvancedMD, Inc. (US) and Qardio, Inc. (US). Players adopted organic as well as inorganic growth strategies such as product upgrades, collaborations, agreements, partnerships, and acquisitions to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

Breakdown of supply-side primary interviews, by company type, designation, and region:

· By Supply Side: Tier 1 (31%), Tier 2 (28%), and Tier 3 (41%)

· By Demand Side: Purchase Managers (45%), Head Of AI, ML, Drud Discovery & Computational Molecular Design (30%), Research Scientists (25%)

· By Designation: C-level (31%), Director-level (25%), and Others (44%)

· By Region: North America (45%), Europe (20%), Asia Pacific (28%), and RoW (7%)

Inquiry Before Buying:

 Recent Developments:

· In May 2023 Medtronic (Ireland) acquired EOFlow Co. Ltd. (South Korea) to expand its ability to treat patients with diabetes.

· In March 2023, GE HealthCare (US) partnered with Advantus Health Partners (US) to sign a multi-year contract to expand access to Healthcare Technology Management Services.

· In April 2023, Abbott (US) acquired Cardiovascular Systems, Inc. (CSI) (US) to gain a complementary treatment option for vascular illness. The highly advanced atherectomy technology from CSI prepares vessels for angioplasty or stenting to restore blood flow.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com